Expert Opinion on Drug Delivery (ISSN 1742-5247 [print], 1744-7593 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles covering all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.
The Editors welcome:
Reviews covering delivery technologies, vehicles and devices; nanotechnology; novel formulations; the delivery of specific drug and therapeutic classes; gene/vaccine delivery strategies; modes of entry into the body and applications in certain diseases and disorders
Technology Evaluations reviewing a particular drug delivery technology
Original Research Contributions are welcomed in the form of: 
    - Delivery technologies, vehicles, formulations and devices 
    - The delivery of specific drugs and therapeutic classes 
    - Modes of entry into the body and applications in certain diseases and disorders
Editorials commenting on the various drug delivery strategies which have been, and are being, explored
Guidelines on the application of specific drug delivery systems, or in specific disease indications.
The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and others closely involved in the delivery of drugs and other therapeutic agents.

EDITOR IN CHIEF
Uday Kompella: University of Colorado, CO, USA
 
EDITORIAL ADVISORY BOARD
Mansoor Amiji: Northeastern University, Boston, MA, USA
Nicholas Bodor: University of Florida, Gainesville, FL, USA
Pieter R Cullis: University of British Columbia, Vancouver, Canada
Elias Fattal: University of Paris - South, Paris, France
Warren Finlay: University of Alberta, Alberta, Edmonton, Canada
Hideyoshi Harashima: Hokkaido University, Hokkaido, Japan
Yogeshvar Kalia: University of Geneva, Geneva, Switzerland
Robert Langer: Massachusetts Institute of Technology, Cambridge, USA
Ram I Mahato: University of Nebraska, USA
Ashim Mitra: University of Missouri, Kansas City, MO, USA
Pankaj Modi: Generex Biotechnology Corporation, Canada
Ravin Narain: University of Alberta, Canada
Seshadri Neervannan: Allergan Inc, USA
Steve Newman: Scientific Consultant, Nottingham, England, UK
Abdel Omri: Laurentian University, Sudbury, Ontario, Canada
Nicholas Peppas: University of Texas, Austin, TX, USA
Michael A Repka: University of Mississippi, MS, USA
Christopher Rhodes: Amylin Pharmaceuticals Inc., San Diego, CA, USA
Abraham Rubinstein: Hebrew University of Jerusalem, Jerusalem, Israel
Bruno Sarmento: University of Porto, Portugal
Alan Smith: Altea therapeutics, Atlanta, GA, USA
Thomas Tice: Evonik Degussa Corporation, Birmingham, AL, USA
Vladimir Torchilin: Northeastern University, Boston, MA
Neeraj Vij: John Hopkins University, Baltimore, USA